PureTech Health is a biotherapeutics company engaged in discovering, developing and commercializing medicines for diseases, including inflammatory, fibrotic and immunological conditions, intractable cancers, lymphatic and gastrointestinal diseases and neurological and neuropsychological disorders, among others. Co.'s wholly owned pipeline includes therapeutic candidates, such as LYT-100, a clinical therapeutic candidate that it is pursuing for the treatment of a range of conditions involving inflammation and fibrosis and disorders of lymphatic flow; and LYT-200, a clinical immuno-oncology fully human monoclonal antibody candidate targeting a foundational immunosuppressive protein. We show 1 historical shares outstanding datapoints in our PRTC shares outstanding history coverage, used to compute PRTC market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing PRTC market cap history over the course of time is important for investors
interested in comparing PRTC's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of PRTC versus a peer is one thing; comparing
PRTC market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like PRTC can fluctuate over the course of history.
With this page we aim to empower investors researching PRTC by allowing them to research the PRTC market cap history. |
Free PRTC Email Alerts:
Video: The Importance of Market Cap
